Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03711604 |
Title | Compassionate Use Study of Tenalisib (RP6530) |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Rhizen Pharmaceuticals SA |
Indications | |
Therapies | |
Age Groups: | adult | child | senior |
Covered Countries | USA | POL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California, Hellen Diller Family Comprehensive Cancer Center | San Francisco | California | 94143 | United States | Details | |
Division of Hematology, University of Colorado, | Denver | Colorado | 80045 | United States | Details | |
Cleveland Clinic Taussig Cancer Institute | Cleveland | Ohio | 44195 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Ltd. M.Zodelava Hematology Centre | Tbilisi | Georgia | Details | |||
Medivest - Institute of Hematology and Transfusiology | Tbilisi | Georgia | Details | |||
Silesian Healthy Blood Clinic Grosicki, Grosicka Sp.J. | Chorzów | 41-503 | Poland | Details |